Informa’s (INF) Buy Rating Reiterated at Panmure Gordon

Informa (LON:INF)‘s stock had its “buy” rating reiterated by equities research analysts at Panmure Gordon in a report released on Wednesday,Digital Look reports. They presently have a GBX 1,200 price target on the stock. Panmure Gordon’s price objective points to a potential upside of 31.75% from the company’s current price.

A number of other research analysts also recently weighed in on INF. JPMorgan Chase & Co. started coverage on shares of Informa in a report on Wednesday, September 3rd. They set an “overweight” rating and a GBX 1,020 price target on the stock. UBS Group restated a “buy” rating and set a GBX 1,055 target price on shares of Informa in a report on Friday, November 7th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Informa from GBX 1,000 to GBX 1,140 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. Five equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of GBX 1,069.

Informa Stock Up 0.1%

INF traded up GBX 1.20 during midday trading on Wednesday, hitting GBX 910.80. 1,974,798 shares of the company’s stock traded hands, compared to its average volume of 10,728,705. The company has a market cap of £11.69 billion, a PE ratio of 165.60, a price-to-earnings-growth ratio of 0.75 and a beta of 1.12. The stock’s fifty day simple moving average is GBX 932.96 and its 200-day simple moving average is GBX 866.88. The company has a debt-to-equity ratio of 31.98, a current ratio of 0.56 and a quick ratio of 1.70. Informa has a one year low of GBX 634.20 and a one year high of GBX 1,000.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.